Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P314. Accuracy of fecal calprotectin in the assessment of post-operative endoscopic recurrence in patients with Crohn's disease
Authors:

G. Boschetti1, D. Moussata1, A.-L. Charlois2, B. Flourié1, S. Nancey1, 1Lyon-Sud Hospital, Gastroenterology, Pierre-Bénite, France, 2Lyon-Sud Hospital, Statistics, Pierre-Bénite, France

P314. Efficacy and safety of T2 for the prevention of postoperative Crohn's disease
P314. Iron supplementation in a large Swiss cohort of IBD patients demonstrates a shift from oral to intravenous therapy over time
P314

Biosimilar infliximab in inflammatory bowel diseases: first interim Results from a prospective nationwide observational cohort

Authors:

K. Gecse*1, K. Farkas2, B. Lovasz1, J. Banai3, L. Bene4, B. Gasztonyi5, P.A. Golovics1, T. Kristof6, L. Lakatos7, P. Miheller8, F. Nagy9, K. Palatka10, M. Papp10, A. Patai11, A. Salamon12, T. Szamosi3, Z. Szepes9, G.T. Toth13, A. Vincze14, T. Molnar2, P. Lakatos1

1Semmelweis University, 1st Department of Medicine, Budapest, Hungary, 2University of Szeged, 1st Department of Medicine, Szeged, Hungary, 3Military Hospital, State Health Centre, Department of Gastroenterology, Budapest, Hungary, 4Peterfy Hospital, 1st Department of Medicine, Budapest, Hungary, 5Zala County Hospital, 2nd Department of Medicine, Zalaegerszeg, Hungary, 6B-A-Z County and University Teaching Hospital, 2nd Department of Medicine, Miskolc, Hungary, 7Csolnoky F. Province Hospital, Department of Medicine, Veszprem, Hungary, 8Semmelweis University, 2nd Department of Medicine, Budapest, Hungary, 9University of Szeged, First Department of Internal Medicine, Szeged, Hungary, 10University of Debrecen, Institute of Medicine, Department of Gastroenterology, Debrecen, Hungary, 11Markusovszky Hospital, 1st Department of Medicine and Gastroenterology, Szombathely, Hungary, 12Tolna County Teaching Hospital, 1st Department of Gastroenterology, Szekszard, Hungary, 13Janos Hospital, Department of Gastroenterology, Budapest, Hungary, 14University of Pecs, 1st Department of Medicine, Pecs, Hungary

P315.

The role of FGF19 in the assessment of diarrhoea and disease activity in non-ileal resected Crohn's disease

Authors:

J. Nolan1, I. Johnston1, J.H. Zhang1, T. Dew2, P. Dixon3, C. Williamson3, J.R. Walters1, 1Imperial College London, Gastroenterology, London, United Kingdom, 2King's College Hospital, Biochemistry, London, United Kingdom, 3Imperial College, Institute of Reproductive and Developmental Biology, London, United Kingdom

P315. Acute infusional reactions to infliximab in an IBD day care centre
P315. Assessment of bowel preparation for colonoscopy: comparison between different tools and different healthcare professionals
Authors:

M. Martinato1, I. Frankovic1, R. Caccaro1, M. Scacchi2, R. Cesaro2, F. Marzari2, F. Colombara2, D. Compagno2, S. Judet2, G.C. Sturniolo1, R. D'Incà1, 1Università degli Studi di Padova, Padova, Italy, 2Azienda Ospedaliera di Padova, Padova, Italy

P315. Infliximab therapy for pediatric inflammatory bowel disease
P315

Remission induction therapy in patients with remitting-relapsing ulcerative colitis dependent and refractory to corticosteroids or intolerant to thiopurines

Authors:

A. Yamada*, H. Iwashita, T. Sasaki, M. Katsumata, M. Miyamura, T. Arai, H. Kikuchi, R. Iwasa, R. Furukawa, K. Sono, A. Osamura, K. Nakamura, H. Aoki, Y. Yoshimatsu, Y. Tsuda, K. Takeuchi, N. Takada, Y. Suzuki

Toho University, Sakura Medical Centre, Division of Gastroenterology, Department of Internal Medicine, Sakura, Japan

P316.

The risk of preoperative anti-TNF-α treatment on early postoperative complications in patients with Crohn's disease

Authors:

S.H. Oh, S.N. Hong, M.J. Kim, E.R. Kim, D.K. Chang, Y.-H. Kim, Samsung Medical Center, Sungkyunkwan University School of Medicine, Medicine, Seoul, South Korea

P316. A distinct phenotype of ulcerative colitis in patients with primary sclerosing cholangitis: a single centre retrospective-descriptive analysis
Authors:

A. Crudeli1, C. Finlayson2, J. Vlahos3, D. Forton1, R. Pollok1, 1St. George's Medical School, Dept. of Gastroenterology, St George's Healthcare NHS Trust, London, United Kingdom, 2St. George's Medical School, Dept. of Histopathology St George's Healthcare NHS Trust, London, United Kingdom, 3St. George's Medical School, Dept. of Radiology, St George's Healthcare NHS Trust, London, United Kingdom

P316. Assessment of liver fibrosis by transient elastography in patients with inflammatory bowel disease undergoing treatment with methotrexate
P316. Stored body iron serum markers are modulated by anti-TNF therapy in inflammatory bowel disease patients
P316

Impact of anti-TNF therapy in the number of hospitalizations and surgeries - Overview of clinical practice in a tertiary referral center

Authors:

P. Sousa*1, P. Santos1, S. Fernandes1, C. Moura1, A. Gonçalves1, A. Valente1, N. Fatela1, C. Baldaia1, F. Serejo1, P. Moura Santos1, J. Malaquias2, L. Correia1, J. Velosa1

1Centro Hospitalar Lisboa Norte, Gastrenterology, Lisbon, Portugal, 2Centro Hospitalar Lisboa Norte, Surgery, Lisbon, Portugal

P317.

The rate of drug usage and side-effects in inflammatory bowel disease

Authors:

G. Can, A. Tezel, G. Ünsal, A. Üstündag, H. Ümit, A.R. Soylu, Trakya University Faculty of Medicine, Gastroenterology Department, Edirne, Turkey

P317. Cost-effectiveness of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn's disease (CD)
P317. Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics
P317. Volume measurements and 3D modelling of Crohn's perianal fistulas – a novel technique
Authors:

N.A. Yassin1, P.F. Lung2, A. Gupta2, R.K.S. Phillips1, P.E. Edwards3, A.L. Hart4, 1St Mark's Hospital and Academic Institute, Harrow, The Department of Colorectal Surgery, London, United Kingdom, 2St Mark's Hospital and Academic Institute, Harrow, The Department of Radiology, London, United Kingdom, 3Department of Surgical Imaging, Imperial College London, United Kingdom, 4IBD Unit, St Mark's Hospital and Academic Institute, Harrow, London, United Kingdom

P317

Clinical value of routine therapeutic anti-TNF drug monitoring (TDM) in Inflammatory Bowel Disease (IBD) patients in clinical practice

Authors:

M. Guirgis1, D. Bianchetti2, G. Dorta3, P. Michetti1, M. Maillard*3

1Crohn's and Colitis Centre, Gastroenterology, Lausanne, Switzerland, 2University of Lausanne, Gastroenterology and Hepatology, Lausanne, Switzerland, 3Centre Hospitalier Universitaire Vaudois, Gastroenterology and Hepatology, Lausanne, Switzerland

P318.

Therapeutic depletion of myeloid lineage leucocytes in patients with ulcerative colitis: Demographic features of responders and non-responders to this non-pharmacological treatment option

Authors:

T. Tanaka, S. Sugiyama, M. Akagi, H. Goishi, T. Kajihara, T. Miura, Akitsu Hospital, Gastroenterology, Hiroshima, Japan